Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-Ku, Chiba 260-8677 Japan.
Department of Emergency Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295 Japan.
J Intensive Care. 2014 Oct 28;2(1):55. doi: 10.1186/s40560-014-0055-2. eCollection 2014.
This is a guideline for the management of sepsis, developed by the Sepsis Registry Committee of The Japanese Society of Intensive Care Medicine (JSICM) launched in March 2007. This guideline was developed on the basis of evidence-based medicine and focuses on unique treatments in Japan that have not been included in the Surviving Sepsis Campaign guidelines (SSCG), as well as treatments that are viewed differently in Japan and in Western countries. Although the methods in this guideline conform to the 2008 SSCG, the Japanese literature and the results of the Sepsis Registry Survey, which was performed twice by the Sepsis Registry Committee in intensive care units (ICUs) registered with JSICM, are also referred. This is the first and original guideline for sepsis in Japan and is expected to be properly used in daily clinical practice. This article is translated from Japanese, originally published as "The Japanese Guidelines for the Management of Sepsis" in the Journal of the Japanese Society of Intensive Care Medicine (J Jpn Soc Intensive Care Med), 2013; 20:124-73. The original work is at http://dx.doi.org/10.3918/jsicm.20.124.
这是 2007 年 3 月成立的日本重症医学会(JSICM)Sepsis 登记委员会制定的脓毒症管理指南。本指南是基于循证医学制定的,重点介绍了日本特有的、未被《拯救脓毒症运动指南》(SSCG)收录的治疗方法,以及日本与西方国家在治疗方法上存在差异的地方。尽管本指南的方法符合 2008 年 SSCG,但也参考了日本文献和 Sepsis 登记委员会在重症监护病房(ICUs)进行的两次 Sepsis 登记调查的结果,该委员会在 JSICM 注册。这是日本脓毒症的首个原始指南,预计将在日常临床实践中得到妥善应用。本文由日本重症医学会出版的《日本脓毒症管理指南》翻译而来,该杂志于 2013 年发表,20:124-73。原文可在 http://dx.doi.org/10.3918/jsicm.20.124. 查阅。